Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
feeling very ill; feeling nauseous; This non-serious case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 03-JAN-2025, the patient received the 1st dose of Shingrix. On 03-JAN-2025, less than a day after receiving Shingrix, the patient experienced nausea (Verbatim: feeling nauseous). On 07-JAN-2025, the patient experienced feeling unwell (Verbatim: feeling very ill). The outcome of the feeling unwell and nausea were not reported. It was unknown if the reporter considered the feeling unwell and nausea to be related to Shingrix. It was unknown if the company considered the feeling unwell and nausea to be related to Shingrix. Additional Information: GSK Receipt Date: 17-JAN-2025 The reporter reported that she was feeling very ill 4 days afterwards she received a first dose of Shingrix. She was feeling nauseous 4 hours after the shot, woke up in the middle of the night. Also said her physician was concerned of whether or not to receive the second shot, need some guidance on this topic.